DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe02096 Mastoparan-L INLKALAALAKKIL HSV-1 38932240
DRAVPe02097 [I5, R8]Mastoparan INLKILARLAKKIL HSV-1 38932240
DRAVPe02104 GLRC_4 GCRRLCGRLGRRLCRLLCR HIV-1IIIB, HSV-2MS Not Avaialbe
DRAVPe02105 GLRC-3 GLRRLCGRLGRRLCRLLLR HIV-1IIIB, HSV-2MS Not Avaialbe
DRAVPe02106 GLRC-2 GLRCRLGRLLRRLGRCLLR HIV-1IIIB, HSV-2MS Not Avaialbe
DRAVPe02107 GLRC-1 GCRRLLGRLLRRLGRLLCR HIV-1IIIB, HSV-2MS Not Avaialbe
DRAVPe02108 SB2 GSRRPVPIIYCNRRTGRCQRI HIV-1IIIB, HSV-2MS Not Avaialbe
DRAVPe02109 SB1 GSKKPVPIIYCNRRTGKCQRI HIV-1IIIB, HSV-2MS Not Avaialbe
DRAVPe02111 Dermaseptin-S2 ALWFTMLKKLGTMALHAGKAALGAAANTISQGTQ HSV-1 20718719
DRAVPe02118 Gramicidin A VGALAVVVWLWLWLW HIV,HSV 9672588
DRAVPe02137 Aspergillipeptide D VXYXYXYP HSV-1 32192525
DRAVPe02138 Aspergillipeptide E YWV HSV-1 32192525
DRAVPe02139 Simplicilliumtide J XIXYQPXAXTX HSV-1 28578573
DRAVPe02140 Verlameline A SAPQYV HSV-1 28578573
DRAVPe02141 Acremonpeptide A FLSX₃ HSV-1,HSV-2 31503476
DRAVPe02142 Al(III)-acremonpeptide D FLWXOX HSV-1 31503476
DRAVPe02143 Myticin C QSVACRSYYCSKFCGSAGCSLYGCYLLHPGKICYCLHCSR HSV-1 27307570
DRAVPe02144 Pa-MAP HTASDAAAAAALTAANAAAAAAASMA HSV-1 27161201
DRAVPe02225 Brevinin-1 FLPVLAGIAAKVVPALFCKITKKC HSV 10795591
DRAVPe02252 B-HR1 AGDNATVAAGHATLREHLRDIKAENTDAN HSV-1 16603508
DRAVPe02253 H-HR1 TARLQLEARLQHLVAEILEREQSLALHALGYQLAFV HSV-1 16603508
DRAVPe02254 H-HR1-SN LQLEARLQHLVAEILER HSV-1 16603508
DRAVPe02255 H-HR1-scrambled YQFHLVLHEALRAQALSRQLILGRELAQELVAELAT HSV-1 16603508
DRAVPe02256 H-HR2 RARRSLLIASALCTSDVAAATNADLRTALARADHQKTLFWL HSV-1 16603508
DRAVPe02257 H-HR2-S TSDVAAATNADLRTALARADHQKTLFWL HSV-1 16603508
DRAVPe02258 H-HR2-scrambled HATCSLAFALATSVALATRNDLLLRWAAARDAQTILSKRDR HSV-1 16603508
DRAVPe02259 B-HR1-S AGHATLREHLRDIKAENTDAN HSV-1 16603508
DRAVPe02260 B-HR1-scrambled TAAGDARANAVAKAGLHDLNIETDTERNH HSV-1 16603508
DRAVPe02261 B-HR2 VEGQLGENNELRLTRDAIE HSV-1 16603508
DRAVPe02262 B-HR2-S GENNELRLTRDAI HSV-1 16603508
First 1 2 3 4 5 6 7 Last